Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance

被引:108
作者
Huang, Wendy [1 ]
Glass, Christopher K. [1 ]
机构
[1] Univ Calif San Diego, Dept Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
immune system; molecular biology; pharmacology; receptors; inflammation; NF-KAPPA-B; TOLL-LIKE RECEPTORS; LIVER-X-RECEPTORS; LOW-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; PPAR-GAMMA; GLUCOCORTICOID-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; INSULIN-RESISTANCE; REDUCES ATHEROSCLEROSIS;
D O I
10.1161/ATVBAHA.109.191189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue inflammation is a tightly regulated process that normally serves to recruit the immune system to sites of infection and injury and to facilitate tissue repair processes. When an inflammatory state is excessive or prolonged, local and systemic damage to host tissues can result in loss of normal physiological functions. Here, we briefly review recent studies that advance our understanding of signaling pathways involved in initiation of inflammatory responses at the level of transcription and counterregulation of these pathways by selected members of the nuclear receptor superfamily. Studies of the intersection of nuclear receptors and inflammation have revealed mechanisms of positive and negative transcriptional control that may provide new targets for pharmacological intervention in chronic diseases, such as atherosclerosis. (Arterioscler Thromb Vasc Biol. 2010;30:1542-1549.)
引用
收藏
页码:1542 / 1549
页数:8
相关论文
共 90 条
[1]  
ABE J, 1990, J NUTR SCI VITAMINOL, V36, P21, DOI 10.3177/jnsv.36.21
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY [J].
Arumugam, Thiruma V. ;
Okun, Eitan ;
Tang, Sung-Chun ;
Thundyil, John ;
Taylor, Stephen M. ;
Woodruff, Trent M. .
SHOCK, 2009, 32 (01) :4-16
[4]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[5]   Macrophage expression of peroxisome proliferator-activated receptor-α reduces atherosclerosis in low-density lipoprotein receptor-deficient mice [J].
Babaev, Vladimir R. ;
Ishiguro, Hiroyuki ;
Ding, Lei ;
Yancey, Patricia G. ;
Dove, Dwayne E. ;
Kovacs, William J. ;
Semenkovich, Clay F. ;
Fazio, Sergio ;
Linton, MacRae F. .
CIRCULATION, 2007, 116 (12) :1404-1412
[6]   Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity [J].
Barish, GD .
JOURNAL OF NUTRITION, 2006, 136 (03) :690-694
[7]   A nuclear receptor atlas: Macrophage activation [J].
Barish, GD ;
Downes, M ;
Alaynick, WA ;
Yu, RT ;
Ocampo, CB ;
Bookout, AL ;
Mangelsdorf, DJ ;
Evans, RM .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (10) :2466-2477
[8]   Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-κB inhibition [J].
Beck, Ilse Me ;
Vanden Berghe, Wim ;
Vermeulen, Linda ;
Bougarne, Nadia ;
Cruyssen, Bert Vander ;
Haegeman, Guy ;
De Bosscher, Karolien .
EMBO JOURNAL, 2008, 27 (12) :1682-1693
[9]   LXR signaling couples sterol metabolism to proliferation in the acquired immune response [J].
Bensinger, Steven J. ;
Bradley, Michelle N. ;
Joseph, Sean B. ;
Zelcer, Noam ;
Janssen, Edith M. ;
Hausner, Mary Ann ;
Shih, Roger ;
Parks, John S. ;
Edwards, Peter A. ;
Jamieson, Beth D. ;
Tontonoz, Peter .
CELL, 2008, 134 (01) :97-111
[10]   Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation [J].
Bishop-Bailey, David ;
Bystrom, Jonas .
PHARMACOLOGY & THERAPEUTICS, 2009, 124 (02) :141-150